Pfizer and BioNTech earned more than $3.3 billion in revenue from global sales of their vaccine Comirnaty last year, while Moderna earned $3.2 billion from its vaccine Spikevax, according to ...

Eighteen former city employees have taken their case to federal court after suing Bellingham for being terminated over refusing the COVID-19 vaccine. The plaintiffs — which include former police ...

Moderna collected $3.1 billion in 2024 Spikevax sales and $25 million from its newer mRESVIA. At its peak in 2022, Spikevax brought in $18.4 billion for the company.

Genevant and Arbutus are seeking monetary relief and injunctions against Spikevax and, where applicable, additional Moderna products that Moderna has represented use the same LNP technology ...

Genevant and Arbutus are seeking monetary relief and injunctions against Spikevax ® and, where applicable, additional Moderna products that Moderna has represented use the same LNP technology, ...

Moderna Inc.’s stock erased early losses to gain more than 3% on Friday, after the biotech company posted a wider-than-expected fourth-quarter loss and offered soft guidance for 2025, offsetting ...

Previously considered the domain of office managers and makeup-obsessed teens in the early Noughties, label makers have proven their worth far beyond these seemingly opposing realms. With the ...

Trump Administration Weighs Pulling Funding for Moderna Bird Flu Vaccine, Bloomberg News Reports (Reuters) - U.S. health officials are reevaluating a $590 million contract that was awarded to ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said. The review is part of a ...

Moderna has a 52-week low of $29.25 and a 52-week high of $170.47. Several equities research analysts recently issued reports on MRNA shares. Leerink Partners decreased their target price on ...

Moderna has established itself as a leader in mRNA-based therapeutics and vaccines, with its COVID-19 vaccine, SpikeVax, serving as the company’s primary revenue driver in recent years. However, the ...